Drug buyers often cut promotion while raising prices, research finds

Acquiring companies raised prices and cut promotion for a majority of the branded drugs in a study of biopharmaceutical deals, highlighting how commercial decisions can change after a takeover. Researchers Vardit Landsman and Stefan Stremersch examined 375 branded drugs involved in 73 mergers and acquisitions. For 54% of the drugs, buyers combined higher prices with ... Read more The post Drug buyers often cut promotion while raising prices, research finds appeared first on Market Business News.